2014•Breast CancerRequires access

Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer

Yukako Shiomi-Mouri, Junko Kousaka, Takahito Ando, Rie Tetsuka, Shogo Nakano, Miwa Yoshida, Kimihito Fujii, Miwa Akizuki, Tsuneo Imai, Takashi Fukutomi, Katsumasa Kobayashi

Open publisher page 32 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 32 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Circulating tumor cell, Medicine, Metastatic breast cancer, Breast cancer, Carcinoembryonic antigen, Oncology, Internal medicine, CA15-3

Back to paper search Browse research topics Original source

Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer — Research Paper | ScholarLens